Full Panel of GYN Testing
Our Molecular diagnostic laboratory currently provides the following diagnostic testing:
We use the Aptima Combo 2 assay which utilizes a target capture and transcription mediated amplification technology for the detection and differentiation of ribosomal RNA (rRNA) from Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (GC) from various specimen types listed below. This assay has been FDA approved*.
Qualitative transcription-mediated amplification
1-3 business days.
We use the Roche cobas® HPV test, which is a real time PCR assay that provides specific genotyping information for HPV Types 16 and 18, while concurrently detecting the other 12 high-risk HPV types in a pooled result. ß-globin from cellular input is used as an internal control to assess specimen quality and identify specimens containing factors that inhibit the amplification process. This FDA approved assay is automated on the cobas® 4800 System*.
Liquid Based (ThinPrep, SurePath) - 1 mL.
Automated nucleic acid extraction and real time PCR amplification.
2-5 business days.
We use BD Affirm VPIII assay which is a direct DNA probe hybridization test in use the detection and identification of Candida species, Gardnerella vaginitis and Trichomonas vaginalis nucleic acid in vaginal fluid specimens from patients with symptoms of vaginitis/vaginosis. This assay has been FDA approved.
BD Affirm swab. (Caution: Only 72 hour test window from swab collection time)
Direct DNA probe hybridization.
1-3 business days.
* ThinPrep sample medium is FDA approved for pre/post aliquot HPV, and GC/CT testing.Currently performance characteristics of HPV and GC/CT testing using SurePath sample medium were determined by SPL in a validation study. The FDA has not approved the SurePath sample medium for HPV and GC/CT testing.
Quality Personalized Service.
Our gross dissection department is built on the “Lean Sigma” model which is a “one piece work flow,” that always flows in one direction. Each specimen is handled individually from beginning to end. There is no batching of specimens. Our bar-coding system assigns to each patient a unique 2-D barcode which is affixed to every aspect of that patient's case (e.g. requisition, cassettes, slides etc.), which follows them from beginning to end. Each department scans these barcodes for processing and patient verification.
To compliment this process we’ve taken automation to the cutting edge. Each grossing station is equipped as follows:
All of these tools working together synergistically provide Sierra Pathology Laboratory, Inc with a uniquely superior process, providing efficiency and accuracy.
Over 80% of outpatient surgical pathology cases are processed and a final report completed within 24 hours of receiving the sample in our laboratory. Nearly 95% are completed within 48 hours. For clients who wish to make use of the AutoFax feature of our reporting system, these final reports will be faxed directly to the clients’ office within minutes of being signed out. For many of our clients up and down the Valley, the norm is to receive most reports the day following the surgical procedure.
Most of the Pathologists have Surgical Pathology fellowship training which includes exposure to genitourinary pathology and some also have Cytopathology fellowship and Cytopathology board certification which includes exposure to urinary tract cytology. We have many years of experience with prostate pathology and offer in our laboratory immunostains important for prostate carcinoma diagnosis in small biopsies. On requests, photomicrographs can be placed on prostate biopsy reports.
Currently we operate draw stations located at Family Medical in downtown Fresno and Sang Medical Group. We are still looking for facilities to partner with, if you need a draw station at you site and would like to discuss this opportunity please use the.
We are proud of our affiliations with: